FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Elan topics
Folic Acid
Carbon Dioxide
Antibodies
Immune Response
High Energy
Inorganic Compounds
Electrolysis
Semiconductor Material
Semiconductor
Hydrogen Production From Water
Female Sexual Dysfunction
Dysfunction
Sexual Dysfunction
Mammography
Radiograph

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Elan patents



      
           
This page is updated frequently with new Elan-related patents. Subscribe to the Elan RSS feed to automatically get the update: related Elan RSS feeds.

Subscribe to updates on this page: Elan RSS RSS

Date/App# patent app List of recent Elan-related patents
04/17/14
20140106283
 Ignition method for controlled burning patent thumbnailnew patent Ignition method for controlled burning
A method for igniting plant materials over an area of land, using one or more indeterminate lengths of a rapidly igniting, prolonged burning incendiary strand. The strand may be comprised of means for rapid ignition along the longitudinal axis of the strand, in co-linear arrangement with a solid or semi-solid combustible fuel composition.
04/10/14
20140100232
 Combination treatment for rosacea patent thumbnailCombination treatment for rosacea
The invention relates to a method of treating erythema and/or telangiectasia associated with rosacea in a patient in need thereof by topically administering an effective amount of a combination of brimonidine or a pharmaceutically acceptable salt thereof and oxymetazoline or a pharmaceutically acceptable salt thereof to the site of erythema and/or telangiectasia on the skin of the patient. The invention further relates to topical compositions including the combination of compounds and a pharmaceutically acceptable carrier..
04/10/14
20140100165
 Prevention of kidney injury or disease patent thumbnailPrevention of kidney injury or disease
The present invention relates to a dosage regime of a peptide analogues of [alpha]-melanocyte-stimulating hormone ([alpha]-msh), which possesses an increased efficacy compared to the native [alpha]-msh peptide in the treatment or prevention of kidney injury or disease.. .
04/10/14
20140100162
 Prevention of kidney injury disease patent thumbnailPrevention of kidney injury disease
The present invention relates to a dosage regime of a peptide analogues of [alpha]-melanocyte-stimulating hormone ([alpha]-msh), which possesses an increased efficacy compared to the native [alpha]-msh peptide in the treatment or prevention of kidney injury or disease.. .
04/03/14
20140094588
 Prognostic and therapeutic signature for malignant melanoma patent thumbnailPrognostic and therapeutic signature for malignant melanoma
The present invention relates to a method of predicting the course of disease in a patient having a malignant melanoma, the method comprising determining in melanoma cells comprised in a sample obtained from said malignant melanoma the presence or amount of at least five biomarkers selected from the group comprising or consisting of mtap, pten, bax, bcl-x, β-catenin, cd20, cox-2, cd49d and mlh1, wherein the absence or decreased amount of mtap and β-catenin and/or the presence or increased amount of pten, bax, bcl-x, cd20, cox-2, cd49d and mlh1, is associated with a disadvantageous course of disease.. .
04/03/14
20140093453
 Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors patent thumbnailLabelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors
The present invention also relates to pharmaceutical compositions comprising them and to their use in diagnosis, in particular with spect or pet imaging and in therapy of melanoma via targeted radionuclide therapy.. .
03/27/14
20140088290
 Novel melanoma antigen peptide and uses thereof patent thumbnailNovel melanoma antigen peptide and uses thereof
The present invention relates to novel melanoma antigen peptides and specific t lymphocytes directed to said peptides and the use thereof for treating melanoma.. .
03/20/14
20140080783
 Pharmaceutical combinations for treatment of specific cancers patent thumbnailPharmaceutical combinations for treatment of specific cancers
The present invention relates to the field of oncology and provides compositions and methods for treating specific cancers, including non small cell lung cancer, breast cancer, thyroid cancer, pancreatic cancer, colon cancer, melanoma, hepatoma and adenocarcinoma. Particularly, compositions and methods involving administration, either simultaneously or sequentially, of pharmaceutical combinations comprising (s)—n-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide with other compounds, to patients suffering from cancer are described..
03/20/14
20140080772
 Treatments for melanoma patent thumbnailTreatments for melanoma
The present invention relates to mono- and combination therapies for melanoma, and in particular, metastatic melanoma. Drugs for use in such therapies in include ro 31-8220, bafetinib, and cardiac glycosides..
03/20/14
20140080764
 Drug containing recombinant mistletoe lectins for treating malignant melanoma patent thumbnailDrug containing recombinant mistletoe lectins for treating malignant melanoma
The invention relates to a drug and/or pharmaceutical composition for treating metastatic tumors, in particular of malignant melanoma, above all of stage iv malignant melanoma, and to the use of said drug, in particular the use of said drug in select patient populations.. .
03/20/14
20140080124
Systems and methods for diagnosing a predisposition to develop colon cancer
Systems and methods for diagnosing or characterizing a predisposition to colon cancer are provided. Cell nuclei may be evaluated for the presence or quantity of gamma-h2ax foci.
03/13/14
20140074068
Multi-component method for regenerative repair of wounds implementing photonic wound debridement and stem cell deposition
A new and useful method for regenerative repair of wounds implementing photonic wound debridement and stem cell deposition is presented which consists of a wound assessment and debridement, wound infrastructure building, and cell deposition phases. The present invention allows structured regenerative repair of the wound, utilizes robotic systems to inspect, define and debride the wound, and prints an extracellular matrix on the prepared wound site which speeds healing using developing stem cell technologies.
03/13/14
20140073507
Herbicidal compositions comprising aminopyralid and bentazon
Provided herein are herbicidal compositions containing (a) aminopyralid or an agriculturally acceptable salt or ester thereof and (b) bentazon or an agriculturally acceptable salt thereof. The compositions provide synergistic weed control of undesirable vegetation, e.g., in rice, wheat, barley, oats, rye, sorghum, corn or maize, oilseed rape/canola, vegetables, pastures, grasslands, rangelands, fallowland, turf, tree and vine orchards, aquatics, industrial vegetation management or rights-of-way..
03/13/14
20140073506
Herbicidal compositions comprising aminopyralid and propanil
Provided herein are herbicidal compositions containing (a) aminopyralid or an agriculturally acceptable salt or ester thereof and (b) propanil. The compositions provide synergistic weed control of undesirable vegetation, e.g., in rice, wheat, barley, oats, rye, sorghum, corn or maize, oilseed rape/canola, vegetables, pastures, grasslands, rangelands, fallowland, turf, tree and vine orchards, industrial vegetation management or rights-of-way..
03/13/14
20140073505
Herbicidal compositions comprising aminopyralid and triclopyr
Provided herein are herbicidal compositions containing (a) aminopyralid or an agriculturally acceptable salt or ester thereof and (b) triclopyr or an agriculturally acceptable salt or ester thereof. The compositions provide synergistic weed control of undesirable vegetation, e.g., in rice, wheat, barley, oats, rye, sorghum, corn or maize, oilseed rape or canola, vegetables, pastures, grasslands, rangelands, fallowland, turf, tree and vine orchards, aquatics, industrial vegetation management or rights-of-way..
03/13/14
20140072971
Prame detection assays
Provided herein are molecular assays, including oligonucleotides and other reagents, for the detection and analysis of prame (preferentially expressed antigen in melanoma). The assays find use, for example, as diagnostic and prognostic applications, including use in assessing therapeutic courses of action..
03/13/14
20140072530
Treatment of hiv
We describe methods of treatment of hiv using proopiomelanocortin (pomc) and corticotropin releasing factor (crf) peptides and their products, as well as uses of such peptides in the preparation and medicaments.. .
03/13/14
20140072529
Substituted 2,3-dihydroimidazo[1,2-c]quinazoline salts
The present invention relates:—to 2-amino-n-[7-methoxy-8-(3-morpholin-4-ylpropoxy)-2,3-dihydroimidazo-[1,2-c]quinazolin-5-yl]pyrimidine-5-carboxamide dihydrochloride salt of formula (ii): or a tautomer, solvate or hydrate thereof;—to methods of preparing said dihydrochloride salt;—to said dihydrochloride salt for the treatment and/or prophylaxis of a disease;—to the use of said dihydrochloride salt for the preparation of a medicament for the treatment and/or prophylaxis of a disease, in particular of a hyper-proliferative and/or angiogenesis disorder, more particularly for the treatment or prophylaxis of a cancer, particularly lung cancer, in particular non-small cell lung carcinoma, colorectal cancer, melanoma, pancreatic cancer, hepatocyte carcinoma, pancreatic cancer, hepatocyte carcinoma or breast cancer;—to a pharmaceutical composition comprising said dihydrochloride salt; and to a pharmaceutical combination comprising said dihydrochloride salt in combination with one or more further pharmaceutical agents.. .
03/06/14
20140066458
Methods for treating vascular leak syndrome
Disclosed are methods for treating vascular leak syndrome. Further disclosed are methods for treating vascular leakage due to inflammatory diseases, inter alia, sepsis, lupus, irritable bowel disease.
03/06/14
20140066392
Combination treatments for melanoma
The present invention relates to combination therapies for melanoma, and in particular, metastatic melanoma. Drugs for use in such therapies in include braf inhibitors such as plx 4720 and plx 4734 in combination with ro 31-8220, bafetinib or cardiac glycosides..
03/06/14
20140066306
Synergistic herbicidal composition containing fluroxypyr and penoxsulam, halosulfuron-methyl, imazamox or imazethapyr
An herbicidal synergistic composition containing (a) fluroxypyr and (b) an als inhibitor herbicide, in which the als inhibitor herbicide is penoxsulam, halosulfuron-methyl, imazamox or imazethapyr, provides improved post-emergence weed control in rice, cereal and grain crops, pastures, rangelands, ivm and turf.. .
03/06/14
20140065190
Tumor lysate loaded particles
Dendritic cells containing tumor lysate loaded particles are prepared. The dendritic cells present tumor antigens to elicit the major histocompatibility complex class i pathway and can be used as a vaccine to treat cancer, including ocular melanoma..
03/06/14
20140065173
Tumor lysate loaded particles
Dendritic cells containing tumor lysate loaded particles are prepared. The dendritic cells present tumor antigens to elicit the major histocompatibility complex class i pathway and can be used as a vaccine to treat cancer, including ocular melanoma..
03/06/14
20140065149
Methods for treating melanoma
Methods of inhibiting melanoma tumor growth, methods of treating melanoma and metastatic melanoma, and methods of reducing the frequency of tumor initiating cells (or cancer stem cells) in melanoma tumors are described. The methods described comprise administering a dll4 antagonist (e.g., an antibody that specifically binds the extracellular domain of human dll4) to a subject.
02/27/14
20140057894
Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators
Disclosed herein is a compound of formula i: wherein x, r1, r2, and r3 are as defend herein, or a pharmaceutically acceptable salt thereof to allow the drug to penetrate the cell membrane; or a prodrug, or the compound is labeled with a detectable label or an affinity tag thereof. Also disclosed is a pharmaceutical composition, a method of treating a disorder mediated by melanocortin-4 receptors, and a method of treating obesity using the compounds described..
02/27/14
20140056909
Treating cancer
This document relates to methods and materials involved in treating cancer (e.g., melanoma). For example, methods and materials involved in using an anti-chronic inflammation treatment (e.g., chemotherapy) in combination with a cancer treatment agent (e.g., a cancer vaccine) to treat cancer are provided..
02/27/14
20140056835
Cosmetic composition for skin whitening comprising small molecule-peptide conjugate
The present invention relates to a cosmetic composition for skin whitening comprising a small molecule-peptide conjugate. More specifically, it concerns the cosmetic composition for skin whitening comprising caffeic acid-lg-nh2 or coumaric acid-lg-nh2 as an active ingredient, which inhibits tyrosinase activity and melanin production, thereby showing an excellent skin whitening effect, and having no side effects to the skin by using a peptide component..
02/27/14
20140056834
Cosmetic composition comprising chrysophanol as active ingredient for skin whitening
A novel use of chrysophanol for skin whitening is provided, in which chrysophanol is included in a cosmetic composition as an effective ingredient for skin whitening. The chrysophanol compound has excellent stability and can also effectively inhibit melanin production via mechanism of inhibiting expression and activity of tyrosinase..
02/27/14
20140056831
Treatment and reduction in incidence of skin cancer
A method for treatment of skin cancer in tissue within the skin of a mammal uses the ingestion, injection, infusion or application of an ingredient having a pharmaceutically active phenyl boric acid or salts of a phenyl boric acid to treat the affected tissue. The treatment may be with an amount of ingredient that inhibits the growth of at least one cancer cell line selected from basal cell carcinoma skin lines, and squamous cell carcinoma skin lines and melanoma skin cell lines..
02/20/14
20140051760
Hybrid molecule having mixed retinoic acid receptor agonism and histone deacetylase inhibitory properties
Hybrid molecules comprising a retinoic acid receptor agonist moiety and a histone deacetylase inhibitor (hdac) moiety are disclosed. Hybrid molecule 3 (6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)naphthalene-2-hydroxamic acid) was proven to posses hdac activity while maintaining rar agonist activity.
02/20/14
20140051694
Aminooxazole inhibitors of cyclin dependent kinases
Oxazole derivatives are described. The inventive compounds are useful as kinase inhibitors, and may be used in the treatment of cancer, such as prostate cancer, lung cancer, breast cancer, colon cancer, leukemia, cns cancer, melanoma, ovarian cancer, and renal cancer..
02/20/14
20140050803
Compositions and methods for treatment of melanoma
Described herein are compositions and methods for the prognosis, prevention and treatment of melanoma or melanoma associated symptoms. The compositions are microrna molecules associated with melanoma or with melanoma brain tropism, as well as various nucleic acid molecules relating thereto or derived therefrom..
02/20/14
20140050745
Melanocortin receptor binding conjugates
The present invention relates to melanocortin receptor binding conjugates and methods of making and using the foregoing.. .
02/13/14
20140045924
Melanoma treatments
Provided herein, in some embodiments, are methods for treating melanoma, improving therapeutic effectiveness of drugs and reducing drug toxicity.. .
02/13/14
20140045840
Compounds and methods for kinase modulation, and indications therefor
Compounds and salts thereof, formulations thereof, conjugates thereof, derivatives thereof, forms thereof and uses thereof are described. In certain aspects and embodiments, the described compounds or salts thereof, formulations thereof, conjugates thereof, derivatives thereof, or forms thereof are active on fms protein kinase, or on fms and kit protein kinase, or on fms and flt-3 protein kinase.
02/13/14
20140045182
C-kit oncogene mutations in melanoma
The present invention provides methods of detecting c-kit-dependent-melanoma for diagnostic and prognostic purposes. The invention further provides methods of treating such melanoma by inhibiting c-kit..


Popular terms: [SEARCH]

Elan topics: Folic Acid, Carbon Dioxide, Antibodies, Immune Response, High Energy, Inorganic Compounds, Electrolysis, Semiconductor Material, Semiconductor, Hydrogen Production From Water, Female Sexual Dysfunction, Dysfunction, Sexual Dysfunction, Mammography, Radiograph

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patents related to Elan for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Elan with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         


FreshNews promo



0.1997

3180

1 - 1 - 73